financetom
Business
financetom
/
Business
/
Commerzbank on Overnight News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Commerzbank on Overnight News
Jun 6, 2025 3:50 AM

06:29 AM EDT, 06/06/2025 (MT Newswires) -- Commerzbank in its "European Sunrise" note of Friday highlighted:

Markets: United States Treasuries stabilize into U.S. close, little changed in Asia. U.S. equities close at session lows, futures recover in Asia, regional markets mixed. USD, oil rangebound overnight Thursday.

Fed: Federal Reserve Governor Adriana Kugler says "first-order effect" of tariffs will be on inflation, not growth, supports holding interest rates. Kansas City Federal Reserve Bank President Jeff Schmid also sees tariffs as "likely to push up prices", but is less convinced on effect size. Federal Reserve Bank of Philadelphia President Patrick Harker favors "wait-and-see approach" as U.S. economy remains resilient.

White House: German Prime Minister Friedrich Merz nails White House meeting while Elon Musk/Donald Trump relationship implodes. White House aides scheduled a call for Friday to avoid further escalation (Politico).

U.S.: Atlanta Fed GDPNow for Q2 falls to 3.8% from 4.64%. District judge temporarily halts ban on international Harvard University students.

Trade: The European Commission has changed team for trade negotiations with the U.S., now including close President Ursula von der Leyen aide and Commissioner Maros Sefcovic cabinet member (Reuters). Brazilian President Luiz Inacio Lula da Silva calls for French President Emmanuel Macron to 'open heart' for Mercosur deal.

NATO: Members sign off on most ambitious ramp-up since the Cold War.

Russia-Ukraine war: President Trump says Russia and Ukraine may have to "fight for a little while" before he can broker a deal.

==EUROPE:

ECB: European Central Bank Governing Council (GC) members envisage pause in July, and "some" see the rate cut cycle already finished, while others still back another move probably in September (Bloomberg sources). Reuters reports "a clear majority" prefers steady rates in July and "a few even made the case for an even longer pause." GC member Madis Muller agrees with ECB President Christine Lagarde that rate cycle is almost finished. GC member Jose Luis Escriva stresses data dependence.

==ASIA:

US/China: Trump and Chinese President Xi Jinping agree to more trade talks, Trump accepts an invitation to visit China.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Disney TV chief Walden steers company to historic Emmy gains
Disney TV chief Walden steers company to historic Emmy gains
Sep 13, 2024
LOS ANGELES (Reuters) - The Emmy Awards, the highest honors in television, had evolved into an annual battle for bragging rights between two prestige-TV powerhouses - HBO and Netflix ( NFLX ). This year, Walt Disney ( DIS ) is the company expected to land on top. Under the leadership of veteran television executive Dana Walden, Disney was propelled to...
CGI Completes Acquisition of Aeyon to Boost Services to the U.S. Government
CGI Completes Acquisition of Aeyon to Boost Services to the U.S. Government
Sep 13, 2024
04:33 PM EDT, 09/13/2024 (MT Newswires) -- CGI Inc. (GIB-A.TO) on Friday said CGI Federal, its U.S. unit completed the acquisition of Aeyon, a company involved in digital transformation and Artificial Intelligence technologies for the U.S. Federal government. The company first announced the acquisition on July 31. The price it paid for Aeyon was not disclosed. The acquisition complements and...
FDA Approves Roche Treatment of Multiple Sclerosis Using Halozyme Delivery System
FDA Approves Roche Treatment of Multiple Sclerosis Using Halozyme Delivery System
Sep 13, 2024
03:25 PM EDT, 09/13/2024 (MT Newswires) -- Halozyme Therapeutics ( HALO ) said Friday the US Food and Drug Administration approved Roche's subcutaneous treatment for multiple sclerosis using Halozyme's drug delivery technology for a faster, twice-a-year 10-minute administration. The FDA's approval of Ocrevus Zunovo is based on phase 3 trial data, which showed non-inferior levels of the medicine in the...
Ibotta Insider Sold Shares Worth $530,770, According to a Recent SEC Filing
Ibotta Insider Sold Shares Worth $530,770, According to a Recent SEC Filing
Sep 13, 2024
04:57 PM EDT, 09/13/2024 (MT Newswires) -- Thomas D Lehrman, Director, on September 11, 2024, sold 10,354 shares in Ibotta ( IBTA ) for $530,770. Following the Form 4 filing with the SEC, Lehrman has control over a total of 690,703 shares of the company, with 219,947 shares held directly and 470,756 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1538379/000162828024040365/xslF345X05/wk-form4_1726260698.xml Price: 56.51, Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved